FERTILITY No data available DRIVING AND USING MACHINES Your medicine is unlikely to affect your ability to drive or to operate machinery
February Feb 27: In one of the more closely watched decisions of the first quarter of 2024, the FDA rejected Minerva Neurosciences roluperidone, which had been proposed to treat the negative symptoms of schizophrenia
Ruxolitinib, the first topical JAK inhibitor cream has been approved by the FDA for treating mild to moderate apoptotic dermatosis [356]
The 2025 tariffs could significantly raise the cost and reduce the availability of thyroid, HRT, and GLP-1 medications, especially generics
By helping to maintain a healthy internal environment, you are giving your body the tools it needs to stay resilient
N Engl J Med 2016;375:31122